Intelligent Bio Solutions annual gross margin
2023
2024
2025
2026
Intelligent Bio Solutions's gross margin was 48.63% for fiscal 2026.
View full Intelligent Bio Solutions company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-06-30 | 48.63% | +7.79 pp |
| 2025 | 2025-06-30 | 40.85% | −4.97 pp |
| 2024 | 2024-06-30 | 45.81% | +19.82 pp |
| 2023 | 2023-06-30 | 25.99% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2026 | 2026-06-30 | 46.83% | +7.06 pp |
| Q3 2026 | 2026-03-31 | 50.47% | +3.63 pp |
| Q2 2026 | 2025-12-31 | 51.27% | +14.54 pp |
| Q1 2026 | 2025-09-30 | 46.62% | +6.86 pp |
| Q4 2025 | 2025-06-30 | 39.77% | −72.29 pp |
| Q3 2025 | 2025-03-31 | 46.84% | +25.17 pp |
| Q2 2025 | 2024-12-31 | 36.73% | +10.65 pp |
| Q1 2025 | 2024-09-30 | 39.76% | +10.57 pp |
| Q4 2024 | 2024-06-30 | 112.05% | +104.82 pp |
| Q3 2024 | 2024-03-31 | 21.67% | −46.75 pp |
| Q2 2024 | 2023-12-31 | 26.08% | — |
| Q1 2024 | 2023-09-30 | 29.18% | — |
| Q3 2023 | 2023-03-31 | 7.23% | — |
| Q2 2023 | 2022-12-31 | 68.42% | — |
Across the available reported history, Intelligent Bio Solutions's gross margin increased from 40.85% to 48.63%, a change of +7.79 percentage points. The latest reported quarter, Q4 2026, shows 46.83%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intelligent Bio Solutions filings at SEC.gov ↗